CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced that it has entered into a three year agreement with M.O.S.S. S.r.l. for distribution of the SoftPap Cervical Cell Collector into Italy. M.O.S.S specializes in the distribution and maintenance of medico-surgical devices. M.O.S.S.’s agreement calls for minimum sales of 1mm units the first year, 2mm units the second, 2.5mm units the third year.
